Evidence map›Paper›PMID 21793746›Full record

ReviewThe New England journal of medicine2011

Microbial genomics and infectious diseases.

David A Relman

Abstract readReview
In one paragraph

Review in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Whole-Genome Analysis of a Historical Strain ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Can Gut Microbiota Affect Dry Eye Syndrome?International journal of molecular sciences · 2020
    Review
  12. Rates of increase of antibiotic resistance and ambient temperature in Europe: a cross-national analysis of 28 countries between 2000 and 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The genome, microbiome and evolutionary medicine.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  19. Comparative genomic analysis of multidrug-resistantInfection and drug resistance · 2018
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David A RelmanDepartment of Medicine, Stanford University, Stanford, California, USA. relman@stanford.edu

Funding

EMERGING INFECTIOUS DISEASEST32AI007502 · NIAID · STANFORD UNIVERSITY · PI Prasanna Jagannathan, DAVID A. RELMAN · 1995 to 2026
$6.8M
NIH Director's Pioneer AwardDP1OD000964 · OD · STANFORD UNIVERSITY · PI RELMAN, DAVID A. · 2006 to 2010
$3.4M
NIAID NIH HHS T32 AI007502NIH HHS DP1 OD000964
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genome, BacterialGenome, ViralMetagenomeBacterial InfectionsCommunicable DiseasesDrug DiscoveryGenome, ArchaealGenomicsHumansMolecular EpidemiologySequence Analysis, DNAVaccinesVaccines

Identifiers

PMID21793746
PMCPMC3412127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.